Senate Bill 2008
116th Congress(2019-2020)
Therapeutic Fraud Prevention Act of 2019
Introduced
Introduced in Senate on Jun 27, 2019
Origin Chamber
Senate
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
2008
Congress
116
Policy Area
Commerce
Commerce
Primary focus of measure is business investment, development, regulation; small business; consumer affairs; competition and restrictive trade practices; manufacturing, distribution, retail; marketing; intellectual property. Measures concerning international competitiveness and restrictions on imports and exports may fall under Foreign Trade and International Finance policy area.
Patty Murray
grade
Washington
Arizona
California
California
Colorado
Connecticut
Connecticut
Delaware
Delaware
Hawaii
Hawaii
Illinois
Illinois
Maine
Maryland
Maryland
Massachusetts
Massachusetts
Michigan
Michigan
Minnesota
Minnesota
Nevada
Nevada
New Hampshire
New Hampshire
New Jersey
New Jersey
New Mexico
New Mexico
New York
New York
Ohio
Oregon
Oregon
Pennsylvania
Rhode Island
Rhode Island
Vermont
Vermont
Virginia
Virginia
Washington
Wisconsin
No Senate votes have been held for this bill.
Summary
Therapeutic Fraud Prevention Act of 2019
This bill prohibits commercial conversion therapy, which is a practice or treatment designed to change a person's sexual orientation or gender identity or otherwise change behaviors, thoughts, or expressions related to gender or sexual attraction. This prohibition does not apply to treatment that assists an individual undergoing a gender transition or facilitates identity exploration and development.
June 27, 2019
06/27/2019
Read twice and referred to the Committee on Commerce, Science, and Transportation. (Sponsor introductory remarks on measure: CR S4631-4632)
06/27/2019
Introduced in Senate
Public Record
Record Updated
Nov 1, 2022 1:50:50 PM